The objective is to extend to Masters level the students’ previous knowledge and understanding of cardiovascular pharmacology. The key topics covered in this module will include prevention and treatment of cardiovascular diseases including atherosclerosis, heart failure, hypertension, ischemic heart disease, arrhythmia, and drug-induced cardiovascular toxicity. Several classes of drugs currently used in cardiovascular medicine that were introduced in previous modules will be discussed in more detail, including lipid lowering therapy, anticoagulants, antiplatelet medications, antihypertensives, and anti arrhythmic drugs. Interindividual variability in response to cardiovascular medications will be covered as well as personalisation of drug therapy that has been established in the field of cardiovascular medicine. Several examples of how genetic makeup of an individual can affect response to medications will be discussed. A number of drugs from different clinical areas that have adverse effects on the heart and vascular system will be also covered. The module is taught through lectures. The assessment will take the form of a summative exercise covering aspects of the taught material.